Tracking central line bloodstream infections in Chinese ICUs

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational project will enroll adults in the ICU who have a central venous catheter expected to remain in place for more than 48 hours and follow them until catheter removal or infection. Clinical, catheter, microbiology, and outcome data will be collected to calculate infection incidence per 1,000 catheter-days and to describe timing, pathogens, and associated outcomes. The work will compare incidence and outcomes with published benchmarks and analyze patient- and catheter-level risk factors for CLABSI. Results will quantify hospital stay, mortality, and additional costs associated with catheter-related bloodstream infections.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 1\. Admitted to the ICU with a central venous catheter placed in place and the expected indwelling time exceeds 48 hours (including newly placed central venous catheters or the continued indwelling of existing qualified central venous catheters)

  2\. Patients aged 18 or above

  3\. Sign the informed consent form

Exclusion Criteria:

1. Patients who have had a central venous catheter indwelled for more than 24 hours before being admitted to the ICU (and are not going to have it replaced immediately)
2. Patients who were re-admitted to the ICU during the study period
3. Lactating and pregnant women

Where it's running

• Zhongda Hospital Affiliated to Southeast University
  Nanjing, Jiangsu, China Recruiting

Study contacts

• Study coordinator: cai chenglong
• Email: ccl17381354871@163.com
• Phone: 17381354871

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Improving prevention of catheter-related bloodstream infections in ICUs

  This study is testing a new approach to help hospitals in intensive care units prevent infections related to catheters by making sure doctors and nurses follow the best care practices.

  Recruiting Fudan University · Shanghai, Shanghai Municipality · NCT06085690

• Full-Course ECMO Pathway for Moderate-to-Severe ARDS

  This study tests a standardized, full-course ECMO management pathway to see if it improves care for adults with moderate-to-severe ARDS treated with VV-ECMO in real-world Chinese centers.

  Recruiting at 15 sites Southeast University, China · Beijing and 38 other locations · NCT07726953

• Understanding immune patterns and ECMO strategies to help adults with severe ARDS

  This study tests how different immune and clinical patterns in adults with moderate-to-severe ARDS respond to ECMO and lung-protective care, aiming to improve outcomes.

  Recruiting at 16 sites Southeast University, China · Beijing, Beijing Municipality and 38 other locations · NCT07726940

• Remimazolam sedation in ICU patients on mechanical ventilation

  This study tests whether using remimazolam for sedation helps mechanically ventilated ICU patients recover better compared to another sedative.

  Recruiting Phase 3 Southeast University, China · Nanjing, Jiangsu · NCT07596589

• Bedside bronchoscopy to clear airways in adults on ventilation with atelectasis

  This trial tests whether using bedside flexible bronchoscopy to clear airways helps improve lung aeration in intubated adults with atelectasis and lots of airway secretions.

  Recruiting Southeast University, China · Nanjing, Jiangsu · NCT07594379

• Dexamethasone for sepsis-related ARDS in adults on ventilatory support

  This trial tests whether dexamethasone can help adults with sepsis-associated ARDS on ventilators recover better compared to placebo.

  Recruiting Phase 3 Southeast University, China · Nanjing, Jiangsu and 1 other locations · NCT07576660

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.